Trial Profile
A trial to study the efficacy of intravenous tigecycline in patients with severe Clostridium difficile infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Metronidazole; Vancomycin
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 16 May 2016 New trial record
- 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases